Shanghai Pharma shareholders approve interim dividend, governance changes

Shanghai Pharmaceuticals Holding Co. Ltd. shareholders approved several key resolutions at its second extraordinary general meeting of 2025 on December 9, 2025. A special resolution to abolish the Supervisory Board and amend the Articles of Association passed with 95.7838% of votes. This change, effective from the EGM date, transfers the Supervisory Board's powers to the audit committee of the Board.

Shareholders also approved an ordinary resolution to distribute a cash dividend of RMB1.20 per ten shares for the first half of 2025. This interim cash dividend is expected to be paid on Friday, February 6, 2026, to H Shareholders on record as of Wednesday, December 31, 2025. The dividend for H shares will be paid in Hong Kong dollars at an exchange rate of RMB0.90803 = HK$1.00, resulting in HK$0.13215 per H share (tax inclusive).

Other ordinary resolutions passed included amendments to the Implementation Rules of Cumulative Voting System and the Administrative Measures for Raised Funds, both receiving over 99.8% of votes in favor. The total number of shares carrying voting rights at the EGM was 2,252,731,543.